A detailed history of Ensign Peak Advisors, Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 408,986 shares of RXRX stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
408,986
Previous 408,986 -0.0%
Holding current value
$2.86 Million
Previous $3.07 Million 12.13%
% of portfolio
0.0%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.35 - $10.05 $73,867 - $101,002
10,050 Added 2.52%
408,986 $3.07 Million
Q1 2024

May 14, 2024

BUY
$9.13 - $15.52 $104,273 - $177,253
11,421 Added 2.95%
398,936 $3.98 Million
Q4 2023

Feb 14, 2024

BUY
$5.09 - $10.79 $878,254 - $1.86 Million
172,545 Added 80.26%
387,515 $3.82 Million
Q3 2023

Nov 13, 2023

BUY
$6.59 - $15.86 $301,492 - $725,595
45,750 Added 27.04%
214,970 $1.64 Million
Q2 2023

Aug 14, 2023

BUY
$4.56 - $9.94 $771,643 - $1.68 Million
169,220 New
169,220 $1.26 Million
Q4 2021

Feb 11, 2022

BUY
$16.14 - $21.86 $249,685 - $338,174
15,470 New
15,470 $265,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.26B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.